Taiko Pharmaceutical Co.,Ltd. (TSE: 4574)
Health Care · Health Care Equipment & Supplies · JP
¥257.00
+1.98% today · -9.2% 1Y
Taiko Pharmaceutical Co.,Ltd. (TSE: 4574) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $81.65M and employs 220 people.
Over the last twelve months the share price has lost 9.2%, trading between 246.00 and 317.00.
Tweenvest scores Taiko Pharmaceutical Co.,Ltd. across four factors: quality 68/100, value 56/100, growth 29/100, dividend 32/100. Its strongest factor is quality.
4574 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $81.65M
- Revenue (TTM)
- $40.73M
- P/E
- 18.78
- EPS
- 13.69
- Dividend yield
- 1.36%
- Beta (5Y)
- 0.32
- 52-week high
- ¥317.00
- 52-week low
- ¥246.00
- Avg volume (3M)
- —
- Shares outstanding
- 50.31M
- Employees
- 220
- Next earnings
- —
About Taiko Pharmaceutical Co.,Ltd.
Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
- ISIN
- JP3442200006
- Founded
- 1946
- Listed since
- Mar 18, 2009
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OPTUS Pharmaceutical Co., Ltd.KOSDAQ: A131030 | $83.48M | ₩6,360.00 | +1.92% |
| Nexstim PlcHLSE: NXTMH | $83.18M | €9.18 | -0.22% |
| HCmed Innovations Co., Ltd.TWSE: 6934 | $83.16M | NT$73.60 | -0.41% |
| Vuno Inc.KOSDAQ: A338220 | $81.97M | ₩7,870.00 | -5.75% |
| Zomedica Corp.OTCPK: ZOMD.F | $80.86M | $0.08 | -6.13% |
| Crossject Société AnonymeENXTPA: ALCJ | $80.47M | €1.35 | +2.27% |
| A Plus Biotechnology Co., Ltd.TWSE: 6918 | $80.45M | NT$75.50 | +2.58% |
| Pulmonx CorporationNasdaqGS: LUNG | $79.02M | $1.80 | -2.17% |
Figures last refreshed Oct 11, 2026.